Blood products derived from non-human animals for hemostatic control, namely, compositions containing freeze-dried platelets, cellular components of freeze-dried platelets, rehydrated freeze-dried platelets, or rehydrated cellular components of freeze-dried platelets for intravenous administration to control hemostatic properties in non-human animals